BioSpace News Archive

Enochian BioSciences, Inc. announced that it has entered into a definitive securities purchase agreement with several institutional investors for the issuance and sale of an aggregate of 3,866,667 shares of its common stock at a purchase price of $7.50 per share of common stock a registered direct offering priced at-the-market under Nasdaq rules.

Magenta Therapeutics today announced the appointment of Thomas Beetham as Chief Legal Officer.

ReCode Therapeutics today announced that the Company will participate in two upcoming virtual investor conferences in June.

CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting.

Moderna , Inc., today announced that Paul Burton, M.D., Ph.D., F.A.C.C, M.R.C.S will join the Company as Chief Medical Officer, effective July 6, 2021.

Medexus Pharmaceuticals Inc. announced today that it will be presenting at the Raymond James Human Health Innovation Conference on June 21 st , 2021.

Debiopharm today announced the phase II results assessing naratuximab emtansine (Debio 1562, formerly IMGN529) for the treatment of DLBCL and other B-cell malignancies.

Enhanced solution delivers balance of speed and quality to accelerate and expedite DNA to Investigational New Drug in as little as 13 months.

Cerus Corporation is proud to announce its celebration of this year’s World Blood Donor Day.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the appointment of Steven Schoch to the Company’s Board of Directors and as Chair of the Audit Committee.